Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03504709 · ClinicalTrials.gov registry record

REsting and Stimulus-based Paradigms to Detect Organized NetworkS and Predict Emergence of Consciousness

A clinical trial, sponsored by Massachusetts General Hospital.

Completed
Registry status
79
Enrollment target

NCT03504709: Completed study, sponsored by Massachusetts General Hospital.

NCT03504709 is a clinical trial that has completed, run by Massachusetts General Hospital. The registered enrollment target is 79 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT03504709 has completed, sponsored by Massachusetts General Hospital.

COMPLETED
Registry status
79 participants
Enrollment target

Study Summary

The aim of this study is to assess the utility of advanced magnetic resonance imaging (MRI) and electroencephalographic (EEG) technologies for predicting functional outcomes in patients with severe traumatic brain injury (TBI).

Primary Outcome

The Disability Rating Scale (DRS) provides quantitative information regarding functional disability in patients recovering from severe brain injury. The total score on the DRS ranges from 0 to 29 with higher scores indicating a greater degree of disability. DRS subscale scores include eye opening \[score range 0-3\], communication \[score range 0-4\], motor response \[score range 0-5\], cognitive ability for feeding \[score range 0-3\], cognitive ability for toileting \[score range 0-3\], cognit

Trial Details

FieldValue
Enrollment Target 79 participants
Start Date 2018-09-05
Est. Completion 2023-10-23
Massachusetts General Hospital

2,032 total trials

What the finished NCT03504709 record still lists

NCT03504709 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 79 participants, a relatively small participant target.

The record links to 0 conditions, and to 0 interventions.

NCT03504709 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT03504709 about?

NCT03504709 is a clinical study titled "REsting and Stimulus-based Paradigms to Detect Organized NetworkS and Predict Emergence of Consciousness". The aim of this study is to assess the utility of advanced magnetic resonance imaging (MRI) and electroencephalographic (EEG) technologies for predicting functional outcomes in patients with severe traumatic brain injury (TBI).

What is the current status of trial NCT03504709?

This trial is currently completed. The enrollment target is 79 participants. The study started on 2018-09-05. Estimated completion is 2023-10-23.

Who is sponsoring clinical trial NCT03504709?

This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT05798897 · 79 participants · Phase 1

    Safety and Preliminary Efficacy of MT-601 in Patients With Relapsed/Refractory Lymphoma

  • NCT06042439 · 79 participants · NA

    AM vs PM Exercise Training

  • NCT06223555 · 79 participants · NA

    Variability In Mixed Meal Tests: Fixed Versus Adjusted to Energy Needs Caloric Dose

  • NCT01243931 · 80 participants · NA

    Optical Coherence Tomography Guided Transepithelial Phototherapeutic Keratectomy

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03504709, the US trial registry maintained by the National Library of Medicine. NCT03504709 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.